Ryan Specialty Holdings faces securities fraud probe after Q4 revenue growth slows and stock drops 12.8%.

Ryan Specialty Holdings reported slower fourth quarter organic revenue growth of 6.6% in 2025, down from 11.0% the previous year, and a decline in adjusted EBITDAC margin to 29.6%. The company also forecasted only high single-digit revenue growth and flat to slightly lower margins for 2026. Following these disclosures, Ryan's stock price fell 12.78% on February 13, 2026. Pomerantz LLP has launched an investigation into whether Ryan and its executives engaged in securities fraud or unlawful practices, advising affected investors to contact them for potential class action participation.